Evaxion A/S shares new data on EVX-01
- EVX-01 data to be presented at SITC 2026 Annual Meeting
- Phase 2 trial showed 75% ORR in 16 patients
- Three-year data to be presented at ESMO 2026 on Oct 24
Every EDGAR filing for Evaxion A/S (EVAX), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Jens Bitsch-Norhave, new insider at EVAX
Jens Bitsch-Norhave, reporting
Andreas Holm Mattsson, new insider at EVAX (amended)
Andreas Holm Mattsson, reporting
Marianne Soegaard, new insider at EVAX (amended)
Marianne Soegaard, reporting
Lars Aage Staal Wegner, new insider at EVAX (amended)
Lars Aage Staal Wegner, reporting
Helen Katrina Tayton-Martin, new insider at EVAX (amended)
Helen Katrina Tayton-martin, reporting
Birgitte Rono, new insider at EVAX (amended)
Birgitte Rono, reporting
Evaxion A/S, new insider